ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Hemogenyx Pharmaceuticals Plc

Hemogenyx Pharmaceuticals Plc (HEMO)

1,025
0,001
(0,10%)
Geschlossen 11 Dezember 5:30PM

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Current Price
1,025
Gebot
0,95
Fragen
1,10
Volumen
9.783.039
0,909 Tagesbereich 1,00
0,876 52-Wochen-Bereich 6,30
Marktkapitalisierung
Handelsende
1,024
Handelsbeginn
0,95
Letzte Trade
3565
@
1.1
(O)
Letzter Handelszeitpunkt
Finanzvolumen
90.884p
VWAP
0,929
Durchschnittliches Volumen (3 Mio.)
15.176.567
Ausgegebene Aktien
1.401.815.988
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-1,92
Gewinn pro Aktie (EPS)
-0
Erlöse
-
Nettogewinn
-6,69M

Über Hemogenyx Pharmaceuticals Plc

Sektor
Finance Services
Branche
Finance Services
Website
Hauptsitz
London, Gbr
Gegründet
-
Hemogenyx Pharmaceuticals Plc is listed in the Finance Services sector of the Londoner Börse with ticker HEMO. The last closing price for Hemogenyx Pharmaceuticals was 1,02p. Over the last year, Hemogenyx Pharmaceuticals shares have traded in a share price range of 0,876p to 6,30p.

Hemogenyx Pharmaceuticals currently has 1.401.815.988 shares in issue. The market capitalisation of Hemogenyx Pharmaceuticals is £14,35 million. Hemogenyx Pharmaceuticals has a price to earnings ratio (PE ratio) of -1.92.

HEMO Neueste Nachrichten

Hemogenyx Pharmaceuticals PLC Admission of New Ordinary Shares and New ISIN

Hemogenyx Pharmaceuticals PLC 10 December 2024   10 December 2024   Hemogenyx Pharmaceuticals plc  ("Hemogenyx Pharmaceuticals" or the "Company")   Admission of New Ordinary Shares and New...

Hemogenyx Pharmaceuticals PLC Result of Extraordinary General Meeting

Hemogenyx Pharmaceuticals PLC 09 December 2024   9 December 2024   Hemogenyx Pharmaceuticals plc  ("Hemogenyx Pharmaceuticals" or the "Company") Result of Extraordinary General Meeting  ...

Hemogenyx Pharmaceuticals PLC Site Initiation Visit Completed

Hemogenyx Pharmaceuticals PLC 09 December 2024   9 December 2024   Hemogenyx Pharmaceuticals plc  ("Hemogenyx Pharmaceuticals" or the "Company")   Site Initiation Visit Completed   Hemogenyx...

TRADING UPDATES: SDX plots AIM exit; Celadon receives funds

The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Al ...

Hemogenyx Pharmaceuticals PLC CBR Macrophage Delivery Update

Hemogenyx Pharmaceuticals PLC 06 December 2024   6 December 2024   Hemogenyx Pharmaceuticals plc  ("Hemogenyx Pharmaceuticals" or the "Company")   CBR Macrophage Delivery   Breakthrough in...

Hemogenyx Pharmaceuticals PLC Total Voting Rights

Hemogenyx Pharmaceuticals PLC 29 November 2024   29 November 2024   Hemogenyx Pharmaceuticals plc  ("Hemogenyx Pharmaceuticals" or the "Company")   Total Voting Rights   Hemogenyx...

Hemogenyx Pharmaceuticals PLC Notice of Extraordinary General Meeting

Hemogenyx Pharmaceuticals PLC 22 November 2024   22 November 2024   Hemogenyx Pharmaceuticals plc ("Hemogenyx Pharmaceuticals" or the "Company")   Notice of Extraordinary General Meeting...

Hemogenyx Pharmaceuticals PLC IRB Approval for Phase I Clinical Trial

Hemogenyx Pharmaceuticals PLC 22 November 2024   22 November 2024   Hemogenyx Pharmaceuticals plc  ("Hemogenyx Pharmaceuticals" or the "Company")   IRB Approval for Phase I Clinical Trial  ...

Hemogenyx Pharmaceuticals PLC Institutional Investment

Hemogenyx Pharmaceuticals PLC 11 November 2024   11 November 2024   Hemogenyx Pharmaceuticals plc ("Hemogenyx Pharmaceuticals" or the "Company")   Institutional Investment of £600,000...

IN BRIEF: Hemogenyx to launch myeloid leukemia treatment phase 1 trial

euticals PLC - London-based biopharmaceutical company focused on treatments for blood diseases - Schedules the opening ...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.173-14.44073455761.1981.20.90965704351.10473313DE
4-0.047-4.384328358211.0721.80.876219376471.17704752DE
12-0.475-31.66666666671.520.876151765671.27570781DE
26-0.525-33.87096774191.5520.87695551331.29882161DE
52-1.15-52.87356321842.1756.30.87699549261.84004672DE
156-0.725-41.42857142861.756.30.87680424481.90960814DE
260-1.075-51.19047619052.115.3750.87696593303.14576392DE
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
SOUSound Energy Plc
0,975p
(50,00%)
36,55M
COROCoro Energy Plc
0,025p
(42,86%)
133,82M
FARFerro-alloy Resources Limited
10,40p
(42,47%)
11,02M
PPSProton Motor Power Systems Plc
0,29p
(34,88%)
2,2M
KDNCCadence Minerals Plc
3,30p
(32,00%)
5,49M
BLUBlue Star Capital Plc
0,0175p
(-22,22%)
7,03M
SDXSdx Energy Plc
0,525p
(-19,23%)
1,46M
XTRXtract Resources Plc
0,50p
(-16,67%)
3,37M
AWEAlphawave Ip Group Plc
115,60p
(-16,23%)
112,64M
INXI-nexus Global Plc
1,35p
(-14,29%)
650,65k
NTVONativo Resources Plc
0,0024p
(-4,00%)
2,09B
ORCPOracle Power Plc
0,0295p
(-13,24%)
935,26M
SYMESupply@me Capital Plc
0,0037p
(-10,84%)
791,23M
TRPTower Resources Plc
0,026p
(-1,89%)
719,95M
ROCKRockfire Resources Plc
0,165p
(-10,81%)
555,71M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock